Comparing IV versus oral anti-nausea drugs for breast cancer chemotherapy
Treatments studied
Part of Cancer, Skin clinical trials.
This study compares two ways of giving anti-nausea medication: one through an IV (drip) and one as a pill. Both are paired with a newer drug to prevent nausea and vomiting caused by chemotherapy in breast cancer patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 70 years.
- You have been diagnosed with primary invasive breast cancer and are scheduled for chemotherapy (before or after surgery).
- You have not had chemotherapy or radiation for this cancer before.
- Your cancer has not spread to distant organs (like bones, liver, or lungs).
- You must be generally well enough to do your daily activities (ECOG score 0-1).
- Your blood counts and liver/kidney function must be within safe limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if two medicines given together, fosaprepitant and palonosetron, can prevent nausea and vomiting caused by strong chemotherapy given over several days. It's for people who have never had chemo before and are about to start a multi-day treatment for a solid tumor.
This trial tests if giving anti-nausea drugs based on your genetic makeup can better prevent vomiting and nausea from chemotherapy for early breast cancer. You will receive a personalized regimen tailored to your pharmacogenetic profile.
This study tests whether adding aromatherapy (using pleasant scents like lavender) to your standard nausea and vomiting medicines works better at preventing those side effects during strong chemotherapy for breast cancer. If you join, you will either get standard treatment plus aromatherapy or standard treatment alone.
This study compares two anti-nausea medications, rolapitant and palonosetron, to see how well they prevent nausea and vomiting caused by chemoradiotherapy for lung cancer. It aims to help patients feel more comfortable during treatment.
This trial studies whether palonosetron helps prevent nausea and vomiting caused by chemotherapy that has a moderate risk of vomiting. It may help you feel more comfortable during chemo and avoid treatment interruptions from severe nausea.
This study tests two medications (fosrolapitant and palonosetron) to prevent severe nausea and vomiting in patients with esophageal or lung cancer who are receiving chemotherapy combined with immunotherapy. If the medications work well, they could help patients feel better during treatment and complete their cancer care more comfortably.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.